肺动脉高压

fèi dònɡ mài ɡāo yā
  • pulmonary hypertension;PH
肺动脉高压肺动脉高压
  1. 结论:从病理生理的角度看血管紧张素转换酶抑制剂(ACEI)对于治疗先天性心脏病肺动脉高压有确切的作用,但这一作用是有限的。

    Conclusions : The effect of ACEI in the treatment of congenital heart disease children with pulmonary hypertension is affirmative but determinatus .

  2. 合并抗磷脂抗体综合征(APS)的系统性红斑狼疮(SLE)患者出现肺动脉高压的概率增加。

    Antiphospholipid antibody syndrome promoted pulmonary hypertension in systemic lupus erythematosus .

  3. 核因子-κB在低氧性肺动脉高压大鼠肺组织表达的研究

    Expression of NF - κ B in the Lung Tissues of Chronic Hypoxic Rats

  4. 内源性CO在缺氧性肺动脉高压大鼠肺血管重构中的作用

    The role of endogenous carbon monoxide in vascular remodeling in hypoxic pulmonary hypertension

  5. 者存在梗阻型肺动脉高压。4、MR肺动脉成像可较好显示肺动脉大小及分布情况。

    MR pulmonary angiography could fairly show the size and distribution of central pulmonary artery and its branches .

  6. 前列腺素E1对风湿性二尖瓣病变合并肺动脉高压患者血液动力学的影响

    Hemodynamic effects of prostaglandin e_1 in patients with mitral valve disease and pulmonary hypertension

  7. 前列腺素E1与氨力农治疗肺动脉高压疗效比较

    Comparison of effectiveness of prostaglandin E_1 and amrinone on hypoxic pulmonary hypertension in pigs

  8. 压宁定与前列腺素E1对肺动脉高压血流动力学的对比研究

    The comparative study of the urapidIl and prostaglandin E1 on hemodynamics in pulmonary hypertensive

  9. 红花注射液对慢性低O2高CO2肺动脉高压的影响

    Effect of safflower injection on pulmonary hypertension in rat during chronic hypoxia and hypercapnia

  10. 前列腺素E1治疗左心衰竭伴肺动脉高压患者20例的超声学评价

    Echocardiographic evaluation of prostaglandin E_1 therapy on pulmonary hypertension secondary to left heart failure in 20 patients

  11. 血栓素合酶和前列环素合酶基因表达与慢性低O2高CO2性肺动脉高压的关系

    Relationship between thromboxane synthase gene and prostacyclin synthase gene expression and pulmonary hypertension induced by hypoxic hypercapnia

  12. 目的应用射血力(F)评价肺动脉高压时右心室收缩功能。

    Objective To evaluate the systolic function of right ventricule with ejective force ( F ) in pulmonary hypertension .

  13. 目的探讨山茛菪碱(654-Ⅱ)对肺动脉高压(PH)患者心肌再灌注损伤防治机制和心功能保护作用。

    Objective To elucidate anisodamine ( 654 ⅱ) on the prevention of myocardial reperfusion injury and the protective effect of cardiac function .

  14. 脂氧合酶抑制剂乙胺嗪,阻断白三烯生成及部分抑制血栓素B2的增加,可以阻止肺动脉高压形成。

    Diethyl-carbamazine , an inhibitor of lipoxygenase , could both inhibit the production of leukotrienes , partially reduce the increment in TXB2 and abolish endotoxin induced pulmonary hypertension .

  15. ATP对风湿性心脏病肺动脉高压患者血流动力学影响的研究

    Effect of ATP upon haemodynamics of patients with rheumatic heart disease complicated with pulmonary artery hypertension

  16. 延胡索乙素对低O2高CO2肺动脉高压大鼠c-jun、c-fos表达的影响

    The effect of dl-tetrahydropalmatine on pulmonary arterial vascular remodeling induced by chronic hypoxic hypercapnia in rats

  17. 三苯氧胺对低氧性肺动脉高压大鼠平均肺动脉压与IGF-1的影响

    Effect of tamoxifen on mean pulmonary arterial pressure and IGF-1 in hypoxic rats

  18. PGE1对COPD合并缺氧性肺动脉高压的疗效

    The Efficacy of Prostaglandin E1 in the Treatment of COPD with Pulmonary Artery Hypertension

  19. 中国汉族人群中与特发性肺动脉高压相关的VIP和KCNA5基因变异

    VIP Gene Variants Related to Idiopathic Pulmonary Arterial Hypertension in Han Nationality of Chinese Population

  20. 动力性肺动脉高压犬肺动脉PCNA及α-平滑肌肌动蛋白的表达

    Expression of PCNA and α - smooth muscle actin in pulmonary arteries of dogs with dynamic pulmonary hypertension

  21. 缺氧及肺动脉高压导致血管内皮细胞损害,促进ET-1释放是其重要因素。

    Hypoxia and pulmonary hypertension could damage vascular endothelial cells and caused the release of ET-1 .

  22. 目的:探讨凋亡基因Fas和FasL与慢性缺氧肺动脉高压(pulmonaryhypertension,PH)心肌细胞凋亡的关系。

    AIM : To explore the relation of Fas and FasL with cardiac myocyte apoptosis in neonates with hypoxia-induced pulmonary hypertension ( PH ) .

  23. PPD抑制肺动脉高压可能通过影响5-HT作用机制。

    PHT which prevented by PPD might effect mechanism of 5 - HT .

  24. 慢性缺氧肺动脉高压左室心肌细胞凋亡基因Fas和FasL的表达

    Expression of Fas and FasL in the left cardiac myocyte apoptosis of neonates with chronic hypoxia-induced pulmonary hypertension

  25. HIF-1α结合活性及蛋白含量的表达变化在缺氧性肺动脉高压大鼠中的作用和意义

    Determination of HIF-1 α Binding Activity by EMSA in Pulmonary Arteries of Rats With Hypoxia-induced Pulmonary Hypertension

  26. 与以往的疗法相比,ET-1受体拮抗剂被认为是治疗肺动脉高压最有前景的新药。

    Till now , ET-1 receptor antagonist is the most promising drug that can be used for pulmonary hypertension .

  27. Tei指数对肺动脉高压患者右心室功能的研究

    Usefulness of Tei Index for Assessing Right Ventricular Function in Pulmonary Hypertension

  28. 目的肺动脉高压(pulmonaryhypertension,PH)形成以结构和功能的改变为特征,其中包括血管平滑肌细胞的增生和胶原纤维合成的增加。

    Objective Pulmonary hypertension ( PH ) is characterized by structural and functional changes in the lung including proliferation of vascular smooth muscular cells ( VSMCs ) and excessive collagen synthesis .

  29. 结论SLE合并肺动脉高压与病情活动、贫血、及心肾功能不全有关。

    Conclusion : Anemia , lupus activity , kidney failure and heart failure is associated in patients with SLE with PAH .

  30. 目的总结成人先天性心脏病(CHD)合并重度肺动脉高压(PH)的外科治疗经验。

    [ Objective ] To summarize the experiences of surgical treatment of congenital heart disease ( CHD ) with severe pulmonary hypertension ( PH ) in adults .